West Virginia PFAS Exposure: The $450 Million Chemours Settlement Does Not Compensate You — Here Is What Actually Protects Your Family
You saw the headline — $450 million, Chemours, “forever chemicals,” the government made them pay. Maybe you live near the Washington Works plant along the Ohio River, and you have been drinking that water for years. Maybe you or someone you love has kidney cancer, thyroid disease, or a child born too small. Maybe you read that number and thought: finally, someone is going to pay for what happened to us.
We need to tell you something before you read any further, because the company that contaminated your water is counting on you not knowing the difference. That $450 million settlement is between the federal government and Chemours. It resolves the government’s enforcement case. It does not pay you. Not one dollar of it compensates any individual person for their cancer, their medical bills, their property damage, or the family member they lost. Your right to sue — to hold Chemours and DuPont accountable for what they did to your body and your home — is completely separate, completely intact, and something the settlement did not touch at all.
We are Attorney911, The Manginello Law Firm. We handle toxic tort cases — the cases where corporations put dangerous chemicals into the water, the air, and the bodies of the people who live near their plants. Ralph Manginello has spent 27 years in courtrooms, including federal court. Lupe Peña spent years inside a national insurance-defense firm, in the rooms where claims like yours are priced and denied — and now he sits on your side of the table. What follows is everything you need to know about what this settlement means, what it does not mean, and what your family needs to do about it.
The One Fact That Matters Most: The Government’s $450 Million Settlement Is Not Your Settlement
Here is the sentence that matters more than any other on this page: the consent decree between the Justice Department and Chemours resolves only the government’s enforcement action. It does not preclude, settle, resolve, or affect any individual person’s right to sue for personal injury, property damage, medical monitoring, or wrongful death.
That is not our interpretation. The Justice Department said it plainly: the settlement does not resolve DuPont’s liability for past PFAS violations, and the agreement addresses penalties, facility upgrades, and water-supply remediation — not individual compensation. North Carolina’s Attorney General called the deal “an insult to the people of eastern North Carolina” because it does so little for the communities actually contaminated. The consent decree is a regulatory document, not a tort settlement. It is the government saying to Chemours: you broke the law, here is your fine, and here is what you must spend to stop breaking it. It is not the government saying to you: here is money for your cancer.
That distinction is the whole fight. The $450 million breaks down as follows: a $22.5 million civil penalty paid to the government; $90 million in environmental mitigation over 15 years; $60 million for pollution controls at the West Virginia facility; $280 million to supply clean drinking water to communities near the West Virginia and New Jersey sites; and additional controls for the North Carolina facility. Every dollar is earmarked for government penalties, facility engineering, and water-system infrastructure. Not a single dollar is allocated to compensate a person who drank contaminated water and developed kidney cancer.
Now here is the part the company does not want you to understand: the consent decree actually strengthens your individual case. It establishes, as a matter of public record, that Chemours violated the Clean Water Act, the Toxic Substances Control Act, and state environmental laws for over a decade. A federal judge — Judge Joseph Goodwin, who presides in West Virginia and has deep experience with chemical-exposure mass torts — had already ordered Chemours in August 2025 to stop discharging unlawful levels of PFAS into the Ohio River from the Washington Works plant, after the company violated its permit limits for more than five years. When you file an individual claim, you are not starting from scratch. The breach — the fact that illegal discharges happened and continued — is already established by the government’s own case and a federal judge’s order. What you have to prove is that those discharges reached you, exposed you, and caused your disease. That is a very different starting line than most toxic tort plaintiffs face.
“Chemours made this mess, and Chemours should clean it up.”
That was North Carolina’s Attorney General, responding to a settlement he called grossly insufficient for the GenX contamination in the Cape Fear River basin. He was talking about the chemical contamination. But the same logic applies to your body: Chemours made this mess, and if you are sick because of it, Chemours — and DuPont — should be the ones who pay for what it cost you.
What Chemours Discharged — and for How Long
The consent decree documents what happened at three facilities in three states, each discharging PFAS into a major river system that serves as drinking water for downstream communities:
Washington Works — West Virginia (Ohio River): This is the plant near Parkersburg, West Virginia, along the Ohio River. It is the same facility at the epicenter of the C8/PFOA contamination crisis that produced the landmark C8 Science Panel findings linking PFAS exposure to human disease. The Justice Department found that Chemours discharged PFAS into the Ohio River in violation of its Clean Water Act NPDES permit and state laws. The violations continued for over a decade. In August 2025, Judge Goodwin ordered Chemours to stop discharging unlawful levels of cancer-causing chemicals into the Ohio River from this plant, after the West Virginia Rivers Coalition showed the company had been violating its permit limits for more than five years. The consent decree requires 14 specific treatment systems at this facility, at an estimated cost of $60 million.
Fayetteville Works — North Carolina (Cape Fear River): This facility was identified as the primary source of GenX contamination affecting downstream communities, including Wilmington, North Carolina. The Cape Fear River basin is one of the most PFAS-impacted watersheds in the United States. The consent decree requires Chemours to implement controls to reduce PFAS releases from this facility based on a pending independent assessment. North Carolina’s Attorney General blasted the settlement as doing “practically nothing to clean up our water.”
New Jersey Facility (Delaware River): The Delaware River corridor hosts dense industrial infrastructure with multiple PFAS discharge points. New Jersey has been among the most aggressive states in pursuing PFAS manufacturers through both environmental enforcement and toxic tort litigation, with its own state drinking water standards predating federal action. The consent decree requires Chemours to test drinking water near the New Jersey site and provide treated or alternative clean water, at an estimated cost included in the $280 million allocation for West Virginia and New Jersey combined.
All three river systems — the Ohio, the Cape Fear, and the Delaware — serve as drinking water sources for downstream communities. That is the exposure pathway: PFAS discharged into the river travels downstream, enters municipal water intakes, flows through taps into homes, and accumulates in the bodies of the people who drink it, cook with it, and bathe in it. PFAS are called “forever chemicals” because they do not break down. They persist in the environment, they persist in water, and they persist in your body — with human half-lives measured in years, not days. Every glass of water you drank from a contaminated source added to the load already in your blood, and that load does not go away just because the discharge stops.
The violations span the Clean Water Act (illegal discharges without or in excess of NPDES permit limits), the Toxic Substances Control Act (violations of chemical manufacturing and disposal requirements), and parallel state environmental statutes in all three states. The Justice Department found that the violations continued for over a decade — meaning that if you lived near any of these facilities and drank the water during that period, you were exposed to illegal levels of PFAS the entire time.
Who Can Be Held Responsible: The Chemours-DuPont Corporate Structure
If you are going to sue for PFAS exposure, you need to understand the corporate structure — because it was designed to make it harder to figure out who pays.
Chemours Co. is the company named in the consent decree. It is the current operator of all three facilities. It is the entity that discharged PFAS into the Ohio River, the Cape Fear River, and the Delaware River. It is the entity that Judge Goodwin ordered to stop discharging into the Ohio River. It is a publicly traded company with substantial assets and insurance coverage. If you were exposed after 2015, Chemours is your primary target.
But Chemours did not always exist. It was created in 2015 as a spin-off from DuPont (E.I. du Pont de Nemours and Company). DuPont owned and operated all three facilities for many decades — decades during which the contamination was generated, discharged, and accumulated in the environment and in people’s bodies. The spin-off was a corporate restructuring that transferred the chemical manufacturing operations to the new entity (Chemours) while leaving DuPont as the historical owner and operator.
Here is the critical fact: the consent decree explicitly does not resolve DuPont’s liability for past PFAS violations. The Justice Department said this plainly. DuPont — the company that manufactured PFAS at these sites for decades, that built the Washington Works plant, that was the epicenter of the C8/PFOA crisis — remains a potential defendant for contamination generated during its ownership period. That is most of the contamination period. If you were exposed before 2015, DuPont is your target, and DuPont’s liability is explicitly preserved.
There is also Corteva, Inc., another entity in the DuPont spin-off structure. DuPont, Chemours, and Corteva together agreed to pay New Jersey up to $2 billion to settle separate state environmental claims stemming from PFAS. That $2 billion state settlement demonstrates the scale of corporate exposure these entities face — and it is separate from the federal settlement, meaning it does not affect your right to bring an individual claim in any of the three states.
The corporate structure is not a shield. It is a map of defendants. The spin-off from DuPont to Chemours is itself a discoverable corporate transaction — and the question of who assumed what liability, who retained what assets, and who controlled the operations during the contamination period is answered through corporate discovery. The generalist files against the name on the door and misses the decades of ownership that preceded it. The expert names every entity in the chain and traces the liability to the deepest pocket at every stage.
And there are additional targets still to be identified through discovery: waste management contractors who transported or disposed of PFAS-containing materials, engineering firms that designed or maintained the discharge systems, and any parent or affiliate entities that participated in operational decisions. The corporate structure is the first thing we map, and it is rarely as simple as the name on the sign.
The Diseases Linked to PFAS: What the Science Shows
PFAS — per- and polyfluoroalkyl substances — are a family of synthetic chemicals used to make products resistant to water, grease, and stains. They are called “forever chemicals” because they do not degrade in the environment and they do not metabolize in the human body. They bind to serum proteins, concentrate in the liver and kidney, and have human half-lives measured in years. Once they are in your blood, they stay there — accumulating with each exposure, declining only slowly over years after the exposure stops.
The C8 Science Panel — an independent group of epidemiologists established as part of the settlement of a class action lawsuit in West Virginia, studying communities exposed to PFOA from the Washington Works plant — found “probable links” between PFOA exposure and six specific conditions:
Kidney cancer. The C8 Science Panel found a probable link between PFOA exposure and kidney cancer. The world’s leading cancer authority, the International Agency for Research on Cancer (IARC), classified PFOA as a Group 1 carcinogen — carcinogenic to humans — in 2024. If you lived near the Washington Works plant and were diagnosed with kidney cancer, the science connecting your exposure to your disease is stronger than for almost any other environmental exposure.
Testicular cancer. The C8 Science Panel found a probable link between PFOA exposure and testicular cancer. This is a cancer that disproportionately affects younger men and can have devastating effects on fertility and long-term health.
Thyroid disease. The panel found a probable link between PFOA exposure and thyroid disease. PFAS are known endocrine disruptors — they interfere with the body’s hormone systems, and the thyroid is one of the primary targets.
High cholesterol (hypercholesterolemia). A probable link was found between PFOA and elevated cholesterol. This may seem less serious than cancer, but chronic elevated cholesterol is a major risk factor for cardiovascular disease — which the EPA also identified as a health effect of PFAS exposure.
Pregnancy-induced hypertension. The panel found a probable link between PFOA and pregnancy-induced hypertension, including preeclampsia. This is a condition that can threaten both mother and baby, and it is one of the reasons PFAS exposure is particularly dangerous for women of childbearing age.
Ulcerative colitis. A probable link was found between PFOA and ulcerative colitis, a chronic inflammatory bowel disease that can cause severe lifelong symptoms and increase the risk of colon cancer.
Beyond the C8 Science Panel findings, the EPA found that PFAS exposure is associated with cardiovascular disease, certain cancers, and babies being born with low birth weight. The EPA set the health-based goal for PFOA and PFOS in drinking water at zero — meaning the agency concluded there is no amount of these chemicals in drinking water that carries no health risk. The enforceable limit was set at 4.0 parts per trillion — roughly equivalent to four drops of contamination in a thousand Olympic swimming pools.
The proof problem in PFAS cases is what defense lawyers call “ubiquity.” PFAS are in nearly everyone’s blood — they are in food packaging, stain-resistant carpets, nonstick cookware, and consumer products worldwide. The defense will argue: everyone has PFAS in their blood, so you cannot prove that OUR facility caused YOUR disease. The answer is specific causation through dose reconstruction: if you lived near the Washington Works plant, drank water from a system drawing from the Ohio River, and have blood serum PFAS levels elevated above the general population, an exposure reconstruction expert can model your individual dose from facility proximity, water source, and duration of residence. The C8 Science Panel’s probable-link findings provide the general causation foundation. Your serum biomonitoring and exposure history provide the specific causation. Together, they answer the “everyone has it” defense — because not everyone has it at the levels you do, and not everyone lived next to the plant that was discharging it illegally for over a decade.
This is also why biomonitoring matters and why it matters now. PFAS serum levels decline slowly over years after exposure is reduced. The longer you wait to get tested, the less representative your levels are of your historical exposure. Testing should be conducted promptly — while your serum levels still reflect the contamination you received from the facility’s discharges. The blood test is the single strongest piece of specific-causation evidence linking facility discharges to your individual body burden.
West Virginia Law: Your Rights If You Were Exposed
West Virginia is where the consent decree was filed. It is where Judge Goodwin sits — a federal jurist with extensive experience in chemical-exposure mass torts, the same judge who presided over the C8/PFOA litigation that produced the science-panel findings linking PFAS to human disease. If you were exposed to PFAS from the Washington Works plant, West Virginia law is likely to govern your claim, and the legal landscape here is more favorable to toxic tort plaintiffs than in most states.
Medical monitoring. West Virginia has recognized medical monitoring as a compensable cause of action in toxic exposure cases — a doctrine developed significantly through the prior C8/PFOA litigation in this same judicial district. Medical monitoring means that even if you have not yet been diagnosed with a disease, you may be able to recover the cost of periodic diagnostic testing for PFAS-associated conditions: kidney cancer screening, thyroid function testing, cholesterol monitoring, and colonoscopies for ulcerative colitis risk. The rationale is straightforward: you were exposed to a known hazard through no fault of your own, the science says you are at elevated risk for specific diseases, and the company that exposed you should pay for the medical surveillance that will catch those diseases early if they develop. This is a significant damage category, particularly for class or mass tort actions representing entire exposed communities.
Comparative fault. West Virginia follows a modified comparative negligence system. Your recovery is reduced by your percentage of fault, and if you are 50% or more at fault, you cannot recover. But in PFAS contamination cases, this defense has almost no application. You did not choose to drink contaminated water. You did not choose to live near a plant that was illegally discharging forever chemicals into your river. You are an involuntary exposee — you had no knowledge of the contamination and no ability to prevent it. The defense may try to argue that you should have installed a water filter or should have moved, but these arguments are weak against a plaintiff who had no way of knowing what was in their water until the government finally acted. In North Carolina, which is one of the few pure contributory negligence jurisdictions in the country (meaning any plaintiff fault bars recovery entirely), this defense has similarly limited applicability to involuntary environmental exposure plaintiffs.
The discovery rule. All three states — West Virginia, North Carolina, and New Jersey — apply some form of the discovery rule for latent toxic tort injuries. This means the statute of limitations may not begin running until you knew or reasonably should have known of the connection between your exposure and your disease. For someone diagnosed with kidney cancer in 2024 who only recently learned that their drinking water was contaminated with PFAS from the Washington Works plant, the clock may have started very recently — not decades ago when the exposure occurred. This doctrine exists precisely because diseases caused by environmental contamination can take years or decades to develop, and the law recognizes that you cannot be expected to sue for an injury you did not know you had.
The statute of limitations. West Virginia’s personal injury statute of limitations is two years under West Virginia Code § 55-2-12, and the wrongful death statute of limitations is also two years under West Virginia’s wrongful death statute. North Carolina’s personal injury deadline is generally three years, and New Jersey’s is generally two years — but these are state-specific and must be confirmed for your particular situation. The critical interaction is with the discovery rule: the clock does not necessarily start on the date of exposure or even the date of diagnosis. It may start when you knew or should have known that your disease was caused by PFAS exposure from a specific facility. Recent regulatory findings, the consent decree, Judge Goodwin’s August 2025 order, and media coverage of the contamination may all be relevant to when the clock started — or whether it has started yet. The safest move is to consult promptly, because the deadline varies by state, by claim type, and by individual circumstances.
Wrongful death. If you lost a family member to a disease linked to PFAS exposure — kidney cancer, testicular cancer, or another condition the science connects to these chemicals — wrongful death claims may be available. The survival estate can recover medical expenses incurred before death and the conscious pain and suffering the deceased experienced, while wrongful death beneficiaries can recover loss of financial support, loss of consortium, and other damages. The applicable deadline varies by state, and the discovery rule may apply — meaning the clock may not have started until the connection between the death and PFAS exposure was or should have been known. Families who have lost loved ones should consult promptly to preserve their rights.
The Regulatory Framework: What the Law Required — and What Chemours Broke
The consent decree resolves violations of three federal statutory regimes, each of which creates records, imposes duties, and establishes standards that individual plaintiffs can use as evidence in their own cases.
The Clean Water Act. Federal law makes it unlawful to discharge pollutants into the nation’s waters without a permit. The National Pollutant Discharge Elimination System (NPDES) permit is the written promise a company makes to the government about exactly what it may release and in what quantities. When Chemours discharged PFAS into the Ohio River, the Cape Fear River, and the Delaware River in excess of its NPDES permit limits, it broke a federal limit it had agreed to in writing. The NPDES permit is the permit the company violated — and the permit itself is evidence in your case. The Clean Water Act also includes a citizen suit provision that allows private citizens to sue polluters for violations of effluent standards or permit conditions, after giving 60 days’ notice.
The Toxic Substances Control Act. TSCA gives the EPA authority to evaluate and regulate chemical risks. A separate TSCA provision requires PFAS manufacturers to report uses, production volumes, disposal, exposures, and known hazards going back to 2011. This means Chemours was required to compile and retain records of what it knew about PFAS toxicity — and those records are discoverable in individual plaintiff cases. Internal corporate communications about PFAS health risks, exposure assessments, and discharge practices are the punitive-damages engine: they can prove corporate knowledge of the danger and conscious disregard for community safety.
The EPA’s PFAS drinking water regulation. In 2024, the EPA finalized the first-ever National Primary Drinking Water Regulation for PFAS, setting enforceable limits for PFOA and PFOS at 4.0 parts per trillion. The health-based goal was set at zero — the agency’s conclusion that there is no safe level of these chemicals in drinking water. The consent decree requires Chemours to install 14 specific treatment systems at the West Virginia plant and to implement PFAS reduction controls at the North Carolina facility. This regulatory baseline creates a standard that individual plaintiffs can reference as evidence of recognized hazard — the federal government itself has determined that these chemicals are dangerous at any detectable level.
The regulatory landscape is shifting. The current administration has proposed softening certain provisions of the Biden-era PFAS drinking water rule — specifically proposing to rescind limits for some PFAS compounds (PFHxS, PFNA, GenX, and the Hazard Index) while retaining the PFOA and PFOS standards. The compliance deadline for PFOA and PFOS may be extended from 2029 to 2031. These are proposed changes, not final. But here is what does not change regardless of any regulatory rollback: the violations that already occurred are established facts. The consent decree documents them. Judge Goodwin’s August 2025 order documents them. A company cannot retroactively undo a decade of illegal discharges by getting the future rules loosened. Your case is built on what they did, not on what the rules will be next year.
The Evidence Clock: What Records Exist — and How Fast They Can Disappear
If there is one section of this page you should read with urgency, it is this one. PFAS cases are latency cases — the exposure happened years or decades ago, and the disease may have appeared only recently. The proof of what happened, how much was discharged, and what the company knew is scattered across records that are aging, degrading, and in some cases being legally destroyed on corporate retention schedules.
NPDES discharge monitoring reports. These are the self-reported records Chemours was required to submit showing the volume, duration, and concentration of its PFAS discharges. They are critical for exposure dose reconstruction — they tell us how much PFAS was in the river and when. They are held by Chemours and by EPA/state environmental agencies. Corporate retention schedules may permit destruction; a litigation hold and preservation demand must issue immediately to freeze them.
Internal Chemours and DuPont corporate communications. Emails, memos, risk assessments, health studies, and communications between the two entities during and after the 2015 spin-off — these are the documents that prove corporate knowledge of PFAS health risks and conscious disregard for community safety. They are the punitive-damages engine. Email retention policies vary by company; key custodians retire, leave, or die. The DuPont-to-Chemours spin-off means key personnel from the contamination period are aging. A litigation hold must issue immediately to prevent routine deletion.
Judge Goodwin’s August 2025 order and the complete consent decree record. These are public records — preserved — that establish unlawful conduct. They include the underlying enforcement findings that can be used as established facts in individual plaintiff cases, reducing the burden of proving breach. The public record is safe, but the underlying administrative record and supporting documentation held by agencies may not be permanently maintained on agency servers. Subpoena or FOIA requests should be sent promptly.
Community water system testing data. The sampling results from utilities serving affected areas establish the exposure pathway — the concentrations of PFAS that reached residential tap water. This is the specific-causation bridge between facility discharge and individual plaintiff exposure. Water utilities may archive older sampling data; state environmental agencies vary in retention. Immediate subpoena or FOIA request is recommended.
Employee testimony. Current and former Chemours and DuPont facility personnel have firsthand knowledge of disposal practices, discharge events, internal awareness of PFAS risks, and any operational changes or cover-ups. Employees retire, relocate, and memories fade. The DuPont-to-Chemours spin-off means key personnel from the contamination period are aging — every year that passes, more of them are gone. Identifying and deposing key witnesses is time-sensitive.
Biomonitoring data. Blood serum PFAS levels from exposed community residents are the direct evidence of individual PFAS body burden — the strongest specific-causation evidence linking facility discharges to plaintiff exposure. But here is the clock: serum PFAS levels decline slowly over years after exposure reduction. If you were exposed for years and the discharges have recently been reduced, your current serum levels may be lower than your historical peak — but they are still the best available evidence of your body burden. Testing should be conducted promptly, while levels remain representative of historical exposure. Every year you wait, the number goes down, and the defense argument that your exposure was insignificant gets stronger.
Facility engineering records. Wastewater treatment system designs, maintenance logs, and process documentation show whether treatment systems were adequate, maintained, or knowingly bypassed. They support claims that violations resulted from cost-cutting or deliberate non-compliance rather than accident. Engineering documents may be purged per corporate document retention schedules; physical plant modifications may destroy evidence of prior configurations.
Here is the truth about evidence in toxic tort cases: the records that prove what happened to you are not kept in a vault for your convenience. They sit in corporate filing systems and government databases, subject to retention schedules that allow destruction after set periods. The single most important thing a lawyer does in the first weeks of a PFAS case is send preservation letters — to Chemours, to DuPont, to the water utility, to the state environmental agency, to every entity that holds a piece of the proof — ordering them to freeze those records before they are legally erased. The day you call is the day that clock starts working for you instead of against you.
What Your Case Is Worth: Damages in PFAS Exposure Claims
Individual toxic tort plaintiffs exposed to PFAS from these facilities may pursue a full range of damages. Every case is different — the value depends on your specific disease, your exposure dose, your duration of residence near the facility, your age and earning capacity, and the venue where your case is filed. What follows is the framework, not a promise.
Economic damages are the losses you can put on a spreadsheet: past and future medical expenses for PFAS-linked conditions — cancer treatment, thyroid medication, ongoing monitoring, surgical costs, and the lifetime care that kidney cancer or testicular cancer may require. Lost wages and earning capacity — the income you lost during treatment and the income you will never earn because your disease changed what you can do. Property value diminution — if your home’s water supply was contaminated, the property itself may be worth less. The cost of alternative water supplies — bottled water, filtration systems, and the expense of securing safe drinking water.
Non-economic damages are the human losses no receipt can measure: pain and suffering, emotional distress from living with elevated cancer risk, loss of quality of life, the anxiety of watching your children grow up drinking contaminated water, and the fear that every new symptom might be the disease you were exposed to. In West Virginia, non-economic damages are subject to a statutory cap in certain cases — but the cap’s application and amount depend on the specific claim type and must be confirmed for your situation. Most caps reach non-economic damages and leave the economic stream untouched, which is why rigorous economic proof matters so much.
Medical monitoring is a significant damage category, particularly for class or mass tort actions. The cost of periodic diagnostic testing for PFAS-associated diseases — kidney cancer screening, thyroid function panels, cholesterol monitoring, pregnancy monitoring for hypertension risk, and colonoscopies for ulcerative colitis risk — multiplied across years and across an entire exposed community, can reach $50 million to $200 million or more per affected community.
Punitive damages are strongly supported by the facts of this case. The violations spanned over a decade. A federal judge had already ordered Chemours to stop discharging unlawful levels of PFAS into the Ohio River, and the violations continued. The likely existence of internal corporate documents showing knowledge of PFAS health risks — discoverable through the TSCA reporting requirement and corporate discovery — supports a punitive damages theory based on conscious, willful disregard for community safety. West Virginia’s punitive damages standards must be confirmed for your specific case, but the factual predicate for punishment is extraordinary: a corporation that knew its chemicals were dangerous, that was told by a federal judge to stop, and that kept discharging them into the drinking water of the communities around its plant.
Case value ranges. Based on the scale of corporate exposure (the $450 million federal settlement and the $2 billion New Jersey state settlement), the documented decade-long violations, the prior judicial cease-and-desist order, and the C8 Science Panel’s probable-link findings providing general causation support, individual personal injury claims may range from approximately $500,000 on the low end to $10 million or more on the high end, depending on the specific disease, the strength of specific causation proof, and the venue. Medical monitoring class actions may range from $50 million to $200 million or more per affected community. These are not predictions — they are the range that the documented facts, the regulatory record, and the prior litigation in this same district support. Past results depend on the facts of each case and do not guarantee future outcomes.
The Defense Playbook: What Chemours Will Try — and How We Counter It
The defense in PFAS cases has a predictable set of moves. Each one has a counter. Knowing them before they happen is half the fight.
Play 1: “The government already settled this.” The company will let the headline do the work — $450 million sounds like compensation, and they will not correct the misunderstanding. The counter is the truth: the consent decree resolves only the government’s enforcement action. Individual rights are separate and untouched. The settlement actually helps individual plaintiffs by establishing that violations occurred.
Play 2: “Your disease has other causes.” The defense will argue that your kidney cancer came from smoking, your thyroid disease from genetics, your cholesterol from diet. This is the alternative-causation defense, and it is the primary battleground in every toxic tort case. The counter is specific causation: serum biomonitoring showing elevated PFAS levels, exposure reconstruction modeling your individual dose from facility proximity and water source, the C8 Science Panel’s probable-link findings, and the IARC Group 1 classification of PFOA as a human carcinogen. A toxicologist and epidemiologist can build the causal chain from the facility’s discharge to your water to your blood to your disease.
Play 3: “The statute of limitations has expired.” The defense will argue that years or decades have passed since the exposure and you are too late. The counter is the discovery rule: the clock does not start until you knew or should have known of the connection between your exposure and your disease. For many people, that connection was only recently made public — through the consent decree, through Judge Goodwin’s order, through media coverage of the contamination. The clock may have started very recently, or it may not have started yet. But this is state-specific and fact-specific, and waiting is the one thing that guarantees the clock runs out.
Play 4: “We complied with the rules at the time.” The defense will argue that historical discharges were within permit limits or that the rules were different then. The counter is the consent decree itself: the Justice Department found violations spanning over a decade, and Judge Goodwin found that Chemours violated its permit limits for more than five years. The violations are documented. “We followed the rules” is contradicted by the government’s own findings.
Play 5: The quick settlement offer. A representative — maybe from Chemours, maybe from an insurer, maybe from a claims administrator — may contact you with a settlement offer that sounds significant but is a fraction of what your case is worth. They will offer it before you have had your blood tested, before your exposure dose has been reconstructed, before a life-care plan has been built, and before you understand the full scope of your future medical needs. The counter is simple: never accept a settlement before the full medical picture is clear. The first offer is always the floor, not the ceiling. What you say to an insurance adjuster — or to any representative of the company that contaminated your water — can permanently affect your case. Do not give recorded statements. Do not sign releases. Do not accept checks with strings attached.
Play 6: The corporate-structure shield. DuPont will argue that the spin-off means it is not responsible for what Chemours did. Chemours will argue that it is not responsible for what DuPont did before 2015. The counter is that the consent decree explicitly preserves DuPont’s liability for past violations, and that corporate successorship analysis can pierce the spin-off structure. The corporate restructuring is not a wall — it is a map of who pays for which period of contamination.
How a PFAS Case Is Actually Built: From First Call to Resolution
Here is how a case like yours actually moves through the system, step by step:
Week one. The preservation letters go out. We send written demands to Chemours, to DuPont, to the water utility, to the state environmental agency, and to every entity that holds a piece of the evidence — ordering them to freeze NPDES discharge reports, internal corporate communications, water testing data, engineering records, and employee personnel files. The day you call is the day those records are protected from routine destruction.
Weeks two through four. We pull the public record — the consent decree, Judge Goodwin’s August 2025 order, the EPA enforcement file, the state environmental agency records, the water utility testing data. We identify which water system served your home and during what period. We map your exposure pathway: facility to river to water intake to your tap to your body.
Months one through three. We arrange biomonitoring — a blood serum PFAS test that measures the current level of forever chemicals in your blood. We gather your medical records — every diagnosis, every treatment, every test result that connects your disease to the exposure. We begin building the exposure reconstruction: where you lived, how long you lived there, what water source you used, and what the PFAS concentrations were in that water during the period you drank it.
Months three through six. We retain experts: a toxicologist to testify about the mechanism by which PFAS causes your specific disease; an epidemiologist to testify about the dose-response relationship; an exposure reconstruction specialist to model your individual dose from facility proximity, water source, and duration of residence; and a life-care planner to build the lifetime cost of your medical care if your disease is chronic or catastrophic. Each expert’s methodology must be documented to survive the defense’s Daubert challenge — the pretrial motion to exclude scientific testimony as unreliable. PFAS cases are expert-driven cases, and the expert selection and methodology documentation are critical from the outset.
Months six through twelve. Discovery begins. We serve document demands on Chemours and DuPont — internal risk assessments, health studies, communications between the entities during and after the spin-off, discharge monitoring reports, engineering records, and everything that shows what they knew and when they knew it. We take depositions — of the environmental compliance managers, of the plant engineers, of the corporate executives who decided to keep discharging after Judge Goodwin told them to stop. The depositions are where the company’s choices are exposed under oath.
Mediation and resolution. The $450 million federal settlement and the $2 billion New Jersey state settlement establish a settlement-value floor for individual claims. These are not your settlements — but they are proof that the defendants have faced and paid massive liability for exactly this conduct. Policy-limit demand letters are crafted to trigger any applicable bad-faith or excess-exposure mechanisms under state law. Mediation is approached with awareness of what these companies have already paid — and with the willingness to try the case if the offer does not reflect the full value of what was taken from you.
Your First Steps: What to Do — and What Not to Do — Right Now
Do get your blood tested for PFAS. A serum PFAS test measures the level of forever chemicals in your blood. It is the single strongest piece of specific-causation evidence in your case. Serum levels decline slowly over years after exposure is reduced — so the sooner you test, the more representative your results are of your historical exposure. Talk to us first about how to get tested and how to preserve the results for litigation.
Do gather your medical records. Pull every record related to your diagnosis — pathology reports, imaging studies, treatment records, medication histories. If you have been diagnosed with kidney cancer, testicular cancer, thyroid disease, high cholesterol, pregnancy-induced hypertension, or ulcerative colitis, those records are the foundation of your damages case. If you have not been diagnosed but lived near the facility, your records establish your baseline health before any PFAS-related disease develops.
Do document your exposure history. Write down where you lived, when you lived there, and what water source you used — municipal water, private well, bottled water. Note the years. Note how close you were to the Washington Works plant (or the Fayetteville Works plant, or the New Jersey facility). Note whether you drank the water, cooked with it, bathed in it. This exposure history is what your reconstruction expert will use to model your dose.
Do not give a recorded statement to anyone. If a representative of Chemours, DuPont, an insurance company, or a claims administrator contacts you, do not answer questions about your health, your exposure, or what you know about the contamination. Anything you say can and will be used to minimize your claim. The only statement that helps you is the one you give to your own lawyer.
Do not sign anything. No release, no waiver, no settlement agreement, no authorization for medical records — not until you have spoken with a lawyer who represents you, not the company. A release you sign today can permanently extinguish your right to sue, even if your disease has not yet been diagnosed.
Do not wait. The statute of limitations is running — and while the discovery rule may help, it is not a guarantee. Evidence is aging — employees are retiring, memories are fading, corporate documents are cycling out of retention schedules. And your serum PFAS levels are declining — every year you wait, the proof in your own blood gets weaker. The day you call is the day the clock starts working for you.
Frequently Asked Questions
Does the $450 million Chemours settlement compensate me for my PFAS exposure?
No. The $450 million consent decree resolves only the federal government’s enforcement action against Chemours. Every dollar is allocated to civil penalties paid to the government, environmental mitigation, facility pollution controls, and drinking water remediation. Not one dollar compensates any individual person for personal injury, medical expenses, property damage, or wrongful death. Your right to sue is completely separate and completely intact.
I lived near the Washington Works plant in West Virginia and was diagnosed with kidney cancer. Can I still sue?
Yes. The government’s settlement does not affect your right to file an individual claim. The consent decree actually strengthens your case by establishing that Chemours violated environmental laws for over a decade. The C8 Science Panel — which studied communities exposed to PFOA from this very facility — found a probable link between PFOA exposure and kidney cancer. The International Agency for Research on Cancer classified PFOA as a Group 1 human carcinogen. You may have a strong claim, but the statute of limitations is running, and you should consult promptly.
What is the deadline to file a PFAS lawsuit in West Virginia?
West Virginia’s personal injury statute of limitations is two years, and the wrongful death statute of limitations is also two years. However, the discovery rule for latent toxic tort injuries means the clock may not start until you knew or reasonably should have known of the connection between your exposure and your disease. For many people, that connection was only recently made public. The deadline varies by state (North Carolina and New Jersey have different periods), by claim type, and by individual circumstances. The safest move is to consult now — waiting is the one thing that guarantees the clock runs out.
My family member died of cancer after years of drinking contaminated water. Is it too late to file a wrongful death claim?
It may not be too late. The discovery rule may apply to wrongful death claims, meaning the deadline may not have started until the connection between the death and PFAS exposure was or should have been known. If your loved one died of kidney cancer, testicular cancer, or another PFAS-linked disease, and you only recently learned that their drinking water was contaminated, the clock may have started recently. Wrongful death and survival claims may be available, with the estate recovering medical expenses and conscious pain-and-suffering damages and beneficiaries recovering loss of financial support and consortium. Consult promptly — these deadlines are unforgiving.
What diseases are linked to PFAS exposure?
The C8 Science Panel found probable links between PFOA exposure and six conditions: kidney cancer, testicular cancer, thyroid disease, high cholesterol, pregnancy-induced hypertension (including preeclampsia), and ulcerative colitis. The EPA also identified cardiovascular disease, certain cancers, and low birth weight as health effects of PFAS exposure. IARC classified PFOA as a Group 1 carcinogen (carcinogenic to humans). If you have been diagnosed with any of these conditions and lived near a Chemours or DuPont facility, your disease may be connected to your exposure.
How do I prove my cancer was caused by PFAS and not something else?
This is the specific-causation question — the central battleground in every toxic tort case. The defense will argue your disease had other causes. We counter with three pieces of evidence: (1) serum biomonitoring — a blood test showing elevated PFAS levels in your body; (2) exposure reconstruction — an expert model of your individual dose based on where you lived, what water you drank, and how long you were exposed; and (3) general causation science — the C8 Science Panel’s probable-link findings and the IARC Group 1 classification. Together, these build the causal chain from the facility’s discharge to your water to your blood to your disease. Not everyone has PFAS at the levels you do — and not everyone lived next to a plant that was illegally discharging for over a decade.
Is DuPont still liable, or did the Chemours settlement cover everything?
DuPont’s liability is explicitly NOT resolved. The Justice Department stated plainly that the settlement does not resolve DuPont’s liability for past PFAS violations. DuPont owned and operated all three facilities for decades — the period when most of the contamination was generated. The 2015 corporate spin-off that created Chemours did not extinguish DuPont’s liability for what happened during its ownership. DuPont, Chemours, and Corteva have already faced a separate $2 billion settlement with New Jersey — demonstrating the scale of DuPont’s remaining exposure. If you were exposed before 2015, DuPont is a target, and its liability is preserved.
What if I lived near the Fayetteville Works plant in North Carolina instead of West Virginia?
You may have a claim. The consent decree covers the North Carolina facility, which discharged PFAS (including GenX) into the Cape Fear River, affecting downstream communities including Wilmington. North Carolina’s Attorney General called the settlement “an insult to the people of eastern North Carolina” — but his criticism reflects the inadequacy of the government’s deal, not the strength of your individual rights. North Carolina is one of the few pure contributory negligence states, meaning any plaintiff fault bars recovery — but this defense has minimal application to involuntary environmental exposure plaintiffs who had no way of knowing their water was contaminated. North Carolina’s statute of limitations differs from West Virginia’s, so consult promptly to understand your deadline.
Do I need to have my blood tested for PFAS to file a claim?
Biomonitoring — a blood serum PFAS test — is the single strongest piece of specific-causation evidence available. It directly measures the level of forever chemicals in your body and links your individual exposure to the facility’s discharges. While a case can potentially proceed without it, testing dramatically strengthens your claim. Serum PFAS levels decline slowly over years after exposure is reduced, so testing sooner rather than later gives a more accurate picture of your historical exposure. We can help arrange testing and ensure the results are properly preserved for litigation.
How much is my PFAS exposure case worth?
Case value depends on your specific disease, the strength of your specific-causation proof, the duration and intensity of your exposure, your economic losses, and the venue where your case is filed. Individual personal injury claims may range from approximately $500,000 to $10 million or more. Medical monitoring claims for exposed communities may reach $50 million to $200 million or more. The $450 million federal settlement and the $2 billion New Jersey state settlement establish a settlement-value floor — these companies have faced and paid massive liability for this conduct. But every case is different, and past results depend on the facts of each case and do not guarantee future outcomes. An honest evaluation requires reviewing your medical records, your exposure history, and your serum biomonitoring results.
What should I do if an insurance company or Chemours representative contacts me?
Do not speak with them. Do not give a recorded statement. Do not sign anything. Do not accept any check or settlement offer. Any representative of the company that contaminated your water — whether they call themselves a claims adjuster, a representative, or an investigator — is working to minimize what the company pays you. The first offer is always a fraction of what your case is worth, and it is designed to arrive before you understand the full scope of your claim. The only person who should be talking to the company’s representatives is your lawyer. If they contact you, take their name and number, tell them you will have your attorney call them back, and hang up.
Can I join a class action, or do I need to file an individual lawsuit?
It depends on your goals. Medical monitoring claims — the cost of periodic diagnostic testing for PFAS-associated diseases — are often best pursued as class or mass tort actions, because they represent an entire exposed community and the costs are spread across many plaintiffs. Personal injury claims — where you have been diagnosed with a specific disease like kidney cancer — are often better pursued as individual lawsuits, because your damages are unique to you and an individual case allows for a fuller recovery. Many cases proceed as part of a mass tort consolidation (like an MDL) where pretrial work is shared but each plaintiff keeps an individual case. The right approach depends on your situation, and we can help you understand which path serves you best.
Why Attorney911: The People Who Will Stand With You
Ralph Manginello has spent 27 years in courtrooms, including federal court. He was a journalist before he was a lawyer — he knows how to find the story the company does not want told, and he knows how to tell it to a jury. He leads the active $10 million hazing lawsuit against Pi Kappa Phi at the University of Houston, and he has spent his career fighting for people who were hurt by institutions that counted on their silence.
Lupe Peña spent years inside a national insurance-defense firm — the rooms where claims like yours are priced, devalued, and denied. He knows how the software values your case, how the adjuster decides what to offer, and how the defense picks its expert witnesses. He now uses that insider knowledge for injured clients. He is fluent in Spanish and conducts full consultations in Spanish without an interpreter. Hablamos Español.
We work on contingency. That means: free consultation, no fee unless we win your case. We do not get paid unless you get paid. The consultation costs nothing and is completely confidential. The first thing we do is listen — to what happened to you, to what you are afraid of, to what you need. Then we tell you honestly whether we can help, and if we are not the right fit, we will tell you that too.
The $450 million settlement is not your settlement. But it is proof that what happened to you is real, that the government documented it, and that the company that did it has been forced to acknowledge it. Your case — your cancer, your thyroid disease, your child’s low birth weight, the family member you lost — is separate from that settlement, and it is worth fighting for.
The clock is running. The evidence is aging. The PFAS in your blood is declining. Every day you wait is a day the company gets stronger and your proof gets weaker.
Call 1-888-ATTY-911. 24/7. We answer — not an answering service, a live person. The consultation is free. The call is the first step.
Past results depend on the facts of each case and do not guarantee future outcomes. This page is legal information, not legal advice. Contacting the firm is free and confidential. We serve families in English and in Spanish. We handle toxic tort cases in West Virginia and nationwide.